Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

121. Computer-aided detection with full-field digital mammography

Computer-aided detection with full-field digital mammography Computer-aided detection with full-field digital mammography Computer-aided detection with full-field digital mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 (...) years of TEC Assessments. To request older reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Computer-aided detection with full-field digital mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 21(3). 2006 Authors' objectives The objective of this assessment is to evaluate the impact of using computer-aided detection (CAD) vs. single reading on the sensitivity, specificity, and biopsy rates for full-field digital

Health Technology Assessment (HTA) Database.2006

122. Should we recommend mammography screening for women between the ages of 40-50?

Should we recommend mammography screening for women between the ages of 40-50? Should we recommend mammography screening for women between the ages of 40-50? | Clinical Correlations Should we recommend mammography screening for women between the ages of 40-50? December 22, 2006 In a recent article in the Lancet, this question was addressed by a group of investigators led by Sue Moss, Ph.D. from the University of Leeds. Currently, the National Cancer Institute, U.S. Preventative Health Services (...) Task Force and the American Cancer Society all recommend screening at a younger age(those between 40-50). The task force, however, does recommend educating your patients about the potential risks/benefits regarding mammography at a younger age. Screening women older than 50 has been shown to reduce mortality from breast cancer by about 25%. Benefit in younger women has been previously suggested in multiple trials. In fact, a meta-analysis of the trials showed a 15% reduction in breast cancer

Clinical Correlations2006

123. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. 16609086 2006 04 12 2006 04 14 2016 10 17 1538-3598 295 14 2006 Apr 12 JAMA JAMA Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. 1647-57 The Women's Health Initiative Estrogen-Aone trial comparing conjugated equine estrogens (CEE) with placebo was stopped early because of an increased stroke (...) incidence and no reduction in risk of coronary heart disease. Preliminary results suggesting possible reduction in breast cancers warranted more detailed analysis. To determine the effects of CEE on breast cancers and mammographic findings. Following breast cancer risk assessment, 10,739 postmenopausal women aged 50 to 79 years with prior hysterectomy were randomized to CEE or placebo at 40 US clinical centers from 1993 through 1998. Mammography screenings and clinical breast examinations were performed

JAMA2006

124. Diagnostic performance of digital versus film mammography for breast-cancer screening.

Diagnostic performance of digital versus film mammography for breast-cancer screening. BACKGROUND: Film mammography has limited sensitivity for the detection of breast cancer in women with radiographically dense breasts. We assessed whether the use of digital mammography would avoid some of these limitations. METHODS: A total of 49,528 asymptomatic women presenting for screening mammography at 33 sites in the United States and Canada underwent both digital and film mammography. All relevant (...) information was available for 42,760 of these women (86.3 percent). Mammograms were interpreted independently by two radiologists. Breast-cancer status was ascertained on the basis of a breast biopsy done within 15 months after study entry or a follow-up mammogram obtained at least 10 months after study entry. Receiver-operating-characteristic (ROC) analysis was used to evaluate the results. RESULTS: In the entire population, the diagnostic accuracy of digital and film mammography was similar (difference

NEJM2005

125. Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography

Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website

NIHR HTA programme2005

126. Model of outcomes of screening mammography: information to support informed choices.

Model of outcomes of screening mammography: information to support informed choices. OBJECTIVE: To provide easy to use estimates of the benefits and harms of biennial screening mammography for women aged 40, 50, 60, and 70 years. DESIGN: Markov process model, with data from BreastScreen Australia, the Australian Institute of Health and Welfare, and the Australian Bureau of Statistics. MAIN OUTCOME MEASURE: Age specific outcomes expressed per 1000 women over 10 years. RESULTS: For every 1000 (...) and 10 interval cancers) and five DCIS (all detected at screening). By comparison, among 1000 women aged 50 who decline screening, 20 cancers are diagnosed over 10 years. There are about 0.5, 2, 3, and 2 fewer deaths from breast cancer over 10 years per 1000 women aged 40, 50, 60, and 70, respectively, who choose to be screened compared with women who decline screening at times determined by relevant policy. CONCLUSION: Benefits and harms of screening mammography are relatively finely balanced

BMJ2005 Full Text: Link to full Text with Trip Pro

127. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. OBJECTIVES: To evaluate the effect on breast cancer mortality during the first 10 years of the mammography service screening programme that was introduced in Copenhagen in 1991. DESIGN: Cohort study. SETTING: The mammography service screening programme in Copenhagen, Denmark. PARTICIPANTS: All women ever invited to mammography screening in the first 10 years of the programme. Historical, national

BMJ2005 Full Text: Link to full Text with Trip Pro

128. A systematic review of mammography educational interventions for low-income women

A systematic review of mammography educational interventions for low-income women A systematic review of mammography educational interventions for low-income women A systematic review of mammography educational interventions for low-income women Bailey T M, Delva J, Gretebeck K, Siefert K, Ismail A CRD summary The review concluded that peer-led interventions providing logistical assistance, based on multi-component strategies, are most effective in increasing uptake of mammography screening (...) in low-income women. This conclusion is limited by the presentation of the available evidence, and also needs to be supported by studies that compare peer-led with non peer-led interventions. Authors' objectives To determine the effectiveness of community-based educational interventions in increasing mammography screening in low-income women. Searching MEDLINE, the Cochrane CENTRAL Register, the Cochrane Database of Systematic Reviews and ISI Web of Science were searched for English language publications

DARE.2005

129. Screening mammography: a reassessment

Screening mammography: a reassessment Screening mammography: a reassessment Screening mammography: a reassessment Deck W, Kakuma R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Deck W, Kakuma R. Screening mammography: a reassessment. Montreal: Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS). AETMIS 05 (...) -03 RE. 2005 Authors' objectives This update of two reports by the Conseil d'Evaluation des technologies de la sante (CETS) published in 1990 and 1993 addresses three questions: (1) What is the strength of the scientific evidence on which screening mammography programs are based? (2) What evidence is there in support of screening for women aged 40 to 49 years? (3) What are the implications of research studies for maximizing the effectiveness of modern programs such as the Programme quebecois de

Health Technology Assessment (HTA) Database.2005

130. Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography

Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Taylor P, Champness J, Given-Wilson R, Johnston K, Potts H Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Taylor P, Champness J, Given-Wilson R, Johnston K, Potts H. Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography. Health Technology Assessment 2005; 9(6): 1-72 Authors' objectives The objective of this study was to determine the value of computer-aided detection (CAD) for breast cancer screening. The impact of the R2 ImageChecker (R) on the sensitivity and specificity

Health Technology Assessment (HTA) Database.2005

132. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. CONTEXT: Current recommendations for women who have a BRCA1 or BRCA2 mutation are to undergo breast surveillance from age 25 years onward with mammography annually and clinical breast examination (CBE) every 6 months; however, many tumors are detected at a relatively advanced stage. Magnetic resonance imaging (MRI) and ultrasound may improve the ability (...) to detect breast cancer at an early stage. OBJECTIVE: To compare the sensitivity and specificity of 4 methods of breast cancer surveillance (mammography, ultrasound, MRI, and CBE) in women with hereditary susceptibility to breast cancer due to a BRCA1 or BRCA2 mutation. DESIGN, SETTING, AND PARTICIPANTS: A surveillance study of 236 Canadian women aged 25 to 65 years with BRCA1 or BRCA2 mutations who underwent 1 to 3 annual screening examinations, consisting of MRI, mammography, and ultrasound

JAMA2004

133. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.

Risk for distant recurrence of breast cancer detected by mammography screening or other methods. CONTEXT: Selection of systemic adjuvant therapies for women diagnosed as having breast cancer is based on risk estimations for cancer recurrence. In such estimations, tumors detected by mammography screening are considered to be associated with a similar risk of recurrence as tumors of similar size found by other methods. OBJECTIVE: To compare the risk of recurrence and survival among women (...) with cancerous tumors detected by mammography screening compared with other methods (outside of screening). DESIGN, SETTING, AND PATIENTS: Retrospective study comparing clinical, histopathological, and biological features of cancerous tumors detected by mammography screening compared with tumors detected outside of screening. Women diagnosed as having breast cancer in 1991 or 1992 were identified from the Finnish Cancer Registry (n = 2842). The median follow-up time was 9.5 years. Cancer biological variables

JAMA2004

134. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study.

Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. OBJECTIVES: To examine how lifestyle, hormonal, and other factors influence the sensitivity and specificity of mammography. METHODS: Women recruited into the Million Women Study completed a questionnaire about various personal factors before routine mammographic screening. A sample of 122,355 women aged 50-64 years were followed for outcome

BMJ2004 Full Text: Link to full Text with Trip Pro

135. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. BACKGROUND: The value of regular surveillance for breast cancer in women with a genetic or familial predisposition to breast cancer is currently unproven. We compared the efficacy of magnetic resonance imaging (MRI) with that of mammography for screening in this group of high-risk women. METHODS: Women who had a cumulative lifetime risk of breast cancer of 15 percent or more were (...) screened every six months with a clinical breast examination and once a year by mammography and MRI, with independent readings. The characteristics of the cancers that were detected were compared with the characteristics of those in two different age-matched control groups. RESULTS: We screened 1909 eligible women, including 358 carriers of germ-line mutations. Within a median follow-up period of 2.9 years, 51 tumors (44 invasive cancers, 6 ductal carcinomas in situ, and 1 lymphoma) and 1 lobular

NEJM2004

136. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age.

Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. BACKGROUND: Older women whose life expectancy is less than 5 years are unlikely to benefit from screening mammography or Papanicolaou (Pap) smears. Since life expectancy is better predicted by health status than by age alone, guidelines recommend considering an older woman's general health when making screening decisions. OBJECTIVE: To determine whether screening (...) mammography and Pap smears are targeted to healthy older women and are avoided in women with limited life expectancies. DESIGN: Cross-sectional population-based study. SETTING: California. PATIENTS: 4792 women 70 years of age or older who participated in the California Health Interview Survey between November 2000 and October 2001. MEASUREMENTS: Predictor variables included age and health status. Health status was measured by using the Medical Outcomes Study 12-item Short Form Physical Summary Scale

Annals of Internal Medicine2004

137. Effect of breast augmentation on the accuracy of mammography and cancer characteristics.

Effect of breast augmentation on the accuracy of mammography and cancer characteristics. CONTEXT: Breast augmentation is not associated with an increased risk of breast cancer; however, implants may interfere with the detection of breast cancer thereby delaying cancer diagnosis in women with augmentation. OBJECTIVE: To determine whether mammography accuracy and tumor characteristics are different for women with and without augmentation. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort (...) of 137 women with augmentation and 685 women without augmentation diagnosed with breast cancer between January 1, 1995, and October 15, 2002, matched (1:5) by age, race/ethnicity, previous mammography screening, and mammography registry, and 10 533 women with augmentation and 974 915 women without augmentation and without breast cancer among 7 mammography registries in Denver, Colo; Lebanon, NH; Albuquerque, NM; Chapel Hill, NC; San Francisco, Calif; Seattle, Wash; and Burlington, Vt. MAIN OUTCOME

JAMA2004

138. A cost-effectiveness comparison of three tailored interventions to increase mammography screening

A cost-effectiveness comparison of three tailored interventions to increase mammography screening A cost-effectiveness comparison of three tailored interventions to increase mammography screening A cost-effectiveness comparison of three tailored interventions to increase mammography screening Saywell R M, Champion V L, Skinner C S, Menon U, Daggy J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared three tailored interventions to increase mammography screening. These were tailored telephone counselling, tailored mailing, and a combination of tailored mailing and telephone counselling. These three interventions were compared with usual care (i.e. no intervention). Type of intervention Screening. Economic

NHS Economic Evaluation Database.2004

139. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services

Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services Lynch F L, Whitlock E P, Valanis B G, Smith S K Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology An outreach intervention to increase Pap test and mammography in women aged 52 to 69 years, who are overdue for both of these services, was examined. As part of usual care, the health management organisation (HMO) in which the study was conducted attempts

NHS Economic Evaluation Database.2004

140. Computer aided detection systems in mammography

Computer aided detection systems in mammography Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. Bywood P, Newton S, Merlin T, Braunack-Mayer A, Hiller J E Record Status This is a bibliographic record of a published health technology assessment (...) from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bywood P, Newton S, Merlin T, Braunack-Mayer A, Hiller J E. Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. 2004 Authors' objectives

This Horizon Scanning Report is intended for the use of health planners and policy makers. It provides an assessment of the current state

Health Technology Assessment (HTA) Database.2004